Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Smith

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|March 1, 2023
Gene polymorphisms associated with heterogeneity and senescence characteristics of sarcopenia in chronic obstructive pulmonary diseaseAmy H Attaway, Annette Bellar, Nicole Welch, et al.
Cell Metabolism|December 3, 2014
γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAORobert A Koeth, Bruce S Levison, Miranda K Culley, et al.
Cell Reports. Medicine|October 12, 2022
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillationJessica C Lal, Chengsheng Mao, Yadi Zhou, et al.
Pflugers Archiv : European Journal of Physiology|January 17, 2021
Atrial fibrillation rhythm is associated with marked changes in metabolic and myofibrillar protein expression in left atrial appendageJulie H Rennison, Ling Li, Cheryl R Lin, et al.
The Journal of Biological Chemistry|May 31, 2013
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effectsMaryam Zamanian-Daryoush, Daniel Lindner, Thomas C Tallant, et al.
Circulation. Genomic and Precision Medicine|March 17, 2018
Genetic Control of Left Atrial Gene Expression Yields Insights into the Genetic Susceptibility for Atrial FibrillationJeffrey Hsu, Shamone Gore-Panter, Gregory Tchou, et al.
The Journal of Biological Chemistry|February 22, 2014
Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctionalJoseph A DiDonato, Kulwant Aulak, Ying Huang, et al.
Neuron|June 14, 2008
ApoE promotes the proteolytic degradation of AbetaQingguang Jiang, C Y Daniel Lee, Shweta Mandrekar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 11, 2014
Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in miceBernd Hewing, Saj Parathath, Tessa Barrett, et al.
Journal of the American Heart Association|April 2, 2024
Disulfiram Reduces Atherosclerosis and Enhances Efferocytosis, Autophagy, and Atheroprotective Gut Microbiota in Hyperlipidemic MiceC Alicia Traughber, Kara Timinski, Ashutosh Prince, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Journal of Cachexia, Sarcopenia and Muscle|March 1, 2023
Gene polymorphisms associated with heterogeneity and senescence characteristics of sarcopenia in chronic obstructive pulmonary diseaseAmy H Attaway, Annette Bellar, Nicole Welch, et al.
Cell Metabolism|December 3, 2014
γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAORobert A Koeth, Bruce S Levison, Miranda K Culley, et al.
Cell Reports. Medicine|October 12, 2022
Transcriptomics-based network medicine approach identifies metformin as a repurposable drug for atrial fibrillationJessica C Lal, Chengsheng Mao, Yadi Zhou, et al.
Pflugers Archiv : European Journal of Physiology|January 17, 2021
Atrial fibrillation rhythm is associated with marked changes in metabolic and myofibrillar protein expression in left atrial appendageJulie H Rennison, Ling Li, Cheryl R Lin, et al.
The Journal of Biological Chemistry|May 31, 2013
The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effectsMaryam Zamanian-Daryoush, Daniel Lindner, Thomas C Tallant, et al.
Circulation. Genomic and Precision Medicine|March 17, 2018
Genetic Control of Left Atrial Gene Expression Yields Insights into the Genetic Susceptibility for Atrial FibrillationJeffrey Hsu, Shamone Gore-Panter, Gregory Tchou, et al.
The Journal of Biological Chemistry|February 22, 2014
Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctionalJoseph A DiDonato, Kulwant Aulak, Ying Huang, et al.
Neuron|June 14, 2008
ApoE promotes the proteolytic degradation of AbetaQingguang Jiang, C Y Daniel Lee, Shweta Mandrekar, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 11, 2014
Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in miceBernd Hewing, Saj Parathath, Tessa Barrett, et al.
Journal of the American Heart Association|April 2, 2024
Disulfiram Reduces Atherosclerosis and Enhances Efferocytosis, Autophagy, and Atheroprotective Gut Microbiota in Hyperlipidemic MiceC Alicia Traughber, Kara Timinski, Ashutosh Prince, et al.
Pageof 20